较高基线炎症标志物水平预测老年2型糖尿病患者认知功能下降更明显:爱丁堡2型糖尿病研究10年随访
爱丁堡2型糖尿病研究为前瞻性队列,纳入1066例60至75岁2型糖尿病患者,基线检测C反应蛋白、IL-6、TNF-α、纤维蛋白原及神经心理测试,581例在10年后重复认知测试。结果显示基线纤维蛋白原和IL-6较高与一般认知能力下降更明显相关,部分关联在调整血管及糖尿病相关协变量后仍具统计学显著性,且似乎具有认知域特异性。
要点
- 基线纤维蛋白原和IL-6较高与10年后一般认知能力下降更明显相关。
- IL-6较高与执行功能和抽象推理下降更明显相关,纤维蛋白原和C反应蛋白较高与处理速度下降更明显相关。
- 部分关联在调整血管及糖尿病相关危险因素后仍具统计学显著性。
核心结论
- 较高的基线炎症标志物水平(包括血浆IL-6、纤维蛋白原和C反应蛋白)与老年2型糖尿病患者随后的认知功能下降相关。
- 这种关联至少部分似乎具有特定认知域特异性,并且独立于血管和糖尿病相关危险因素。
研究设计与样本
- 爱丁堡2型糖尿病研究是一项前瞻性队列研究,纳入1066例年龄60至75岁的2型糖尿病成人。
- 基线数据包括C反应蛋白、IL-6、TNF-α、纤维蛋白原及主要认知域的神经心理测试。
- 581例参与者在10年后重复认知测试;采用主成分分析从七项个体认知测试中提取一般认知能力评分。
- 采用线性回归确定基线炎症标志物与随访时认知结局的纵向关联,并将基线认知测试结果作为协变量纳入模型以模拟认知随时间的变化。
主要发现
- 调整年龄、性别和基线一般认知能力后,较高的基线纤维蛋白原和IL-6与一般认知能力下降更明显相关(标准化β分别为-0.059,p=0.032和-0.064,p=0.018)。
- 进一步调整基线血管及糖尿病相关协变量后,上述关联失去统计学显著性。
- 评估与个体认知测试的关联时,较高的IL-6与执行功能和抽象推理测试下降更明显相关(标准化β分别为0.095,p=0.006和-0.127,p=0.001)。
- 同样,升高的纤维蛋白原和C反应蛋白水平与处理速度下降更明显相关(标准化β分别为-0.115,p=0.001和-0.111,p=0.001)。
- 这些关联在调整糖尿病和血管相关危险因素后仍具统计学显著性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to determine the longitudinal association of circulating markers of systemic inflammation with subsequent long-term cognitive change in older people with type 2 diabetes. METHODS: The Edinburgh Type 2 Diabetes Study is a prospective cohort study of 1066 adults aged 60 to 75 years with type 2 diabetes. Baseline data included C-reactive protein, IL-6, TNF-α fibrinogen and neuropsychological testing on major cognitive domains. Cognitive testing was repeated after 10 years in 581 participants. A general cognitive ability score was derived from the battery of seven individual cognitive tests using principal component analysis. Linear regression was used to determine longitudinal associations between baseline inflammatory markers and cognitive outcomes at follow-up, with baseline cognitive test results included as covariables to model cognitive change over time. RESULTS: Following adjustment for age, sex and baseline general cognitive ability, higher baseline fibrinogen and IL-6 were associated with greater decline in general cognitive ability (standardised βs = -0.059, p=0.032 and -0.064, p=0.018, respectively). These associations lost statistical significance after adjustment for baseline vascular and diabetes-related covariables. When assessing associations with individual cognitive tests, higher IL-6 was associated with greater decline in tests of executive function and abstract reasoning (standardised βs = 0.095, p=0.006 and -0.127, p=0.001, respectively). Similarly, raised fibrinogen and C-reactive protein levels were associated with greater decline in processing speed (standardised βs = -0.115, p=0.001 and -0.111, p=0.001, respectively). These associations remained statistically significant after adjustment for the diabetes- and vascular-related risk factors. CONCLUSIONS/INTERPRETATION: Higher baseline levels of inflammatory markers, including plasma IL-6, fibrinogen and C-reactive protein, were associated with subsequent cognitive decline in older people with type 2 diabetes. At least some of this association appeared to be specific to certain cognitive domains and to be independent of vascular and diabetes-related risk factors.
引用
- Sluiman AJ, McLachlan S, Forster RB, et al. Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study. Diabetologia. 2021. PMID: 34932135. doi:10.1007/s00125-021-05634-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。